Enanta Pharmaceuticals Inc (ENTA)
EBITDA Margin
-98.54%
Quarterly · Period ending:
ENTA EBITDA Margin
Latest reported-98.54%period ending
Latest reported-98.54%period ending
ENTA Quarterly EBITDA Margin (0.00% → -98.54%)
Quarterly ebitda margin
High-resolution chart · PNG
ENTA ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -98.5445% | |
| -49.8805% | |
| -40.8327% | |
| -99.1537% | |
| -84.0778% | |
| -140.9085% | |
| -117.0765% | |
| -178.8595% | |
| -111.8691% | |
| -166.1546% | |
| -166.3389% | |
| -135.7332% | |
| -170.4213% | |
| -208.3394% | |
| -120.8777% | |
| -126.3917% | |
| -161.3584% | |
| -175.0908% | |
| -106.2319% | |
| -138.2312% | |
| -150.689% | |
| -143.3837% | |
| -36.0016% | |
| -79.8697% | |
| -117.6004% | |
| -39.6828% | |
| 26.2032% | |
| 14.2693% | |
| 10.4582% | |
| -1.2667% | |
| 40.8322% | |
| 52.2476% | |
| 40.6849% | |
| 39.6649% | |
| 39.2663% | |
| 72.2523% | |
| -167.4477% | |
| -100.2121% | |
| -57.7614% | |
| -16.8367% | |
| -4.6859% | |
| -1.0151% | |
| 74.1728% | |
| 26.9007% | |
| 16.1048% | |
| 84.8955% | |
| 90.7623% | |
| -197.8005% | |
| 83.1918% | |
| -237.3611% | |
| -602.6876% | |
| -343.0689% | |
| -249.6665% | |
| -308.6957% | |
| 78.9799% | |
| -215.9849% | |
| -136.3493% | |
| 87.9338% | |
| -418.7584% | |
| 0% |